Ji-Won Kim
Vorstandsvorsitzender bei AJU IB INVESTMENT CO., LTD.
Vermögen: 262 644 $ am 31.05.2024
Profil
Ji-Won Kim is currently the Chief Executive Officer of Aju IB Investment Co., Ltd.
(Private Equity) and also holds the position of Director at SL VaxiGen, Inc. Prior to this, he was the Chief Executive Officer & Director at AJU IB Investment Co., Ltd.
starting from 1999.
Mr. Kim completed his undergraduate degree from Yonsei University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.05.2024 | 131 755 ( 0,11% ) | 262 644 $ | 31.05.2024 |
Aktive Positionen von Ji-Won Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| AJU IB INVESTMENT CO., LTD. | Vorstandsvorsitzender | 01.01.1999 |
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Vorstandsvorsitzender | - |
SL VaxiGen, Inc.
 SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology SL VaxiGen, Inc. operates as research and development company which engages in developing vaccine therapeutics based on complementary platforms for saving lives. The company was founded on March 3, 2017 and is headquartered in Seongnam, South Korea. | Direktor/Vorstandsmitglied | - |
Ausbildung von Ji-Won Kim
| Yonsei University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AJU IB INVESTMENT CO., LTD. | Finance |
| Private Unternehmen | 2 |
|---|---|
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Finance |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology SL VaxiGen, Inc. operates as research and development company which engages in developing vaccine therapeutics based on complementary platforms for saving lives. The company was founded on March 3, 2017 and is headquartered in Seongnam, South Korea. | Health Technology |
